Potential drug leads for SARS-CoV2 from phytochemicals of Aerva lanata: a Machine Learning approach

被引:2
|
作者
Sherin D.R. [1 ]
Sharanya N. [1 ]
Manojkumar T.K. [1 ]
机构
[1] School of Digital Sciences, Kerala University of Digital Sciences, Innovation and Technology, Thiruvananthapuram
关键词
Aerva lanata; Docking; Machine learning; SARS-CoV-2;
D O I
10.1007/s13337-021-00732-0
中图分类号
学科分类号
摘要
COVID-19 outbreak is the recently reported worldwide pandemic threat. As part of our interventions with machine learning and molecular simulation approaches, we report the inhibitory effect of thirty compounds reported from the sacred plant Aerva lanata. The predicted activity of the screened ligands are comparable with the one of the present medication, hydroxy chloroquine (HCQ), on the main protease (PDB:6YB7) of SARS-CoV-2. Our studies pointed out the effectiveness of the plant with twenty seven compounds having potential activity against the main protease compared to the reference HCQ. The robustness of some of the phytochemicals such as ervoside, which is only present in Aerva lanata computed to have very high anticoronavirus activity. The results are indicative of potential natural antivirus source, which subsidizes in thwarting the invasion of coronavirus into the human body. Many phytochemicals which are computed to be effective towards SARS-CoV-2 in this study are used as drugs for various other diseases. Perhaps these compounds could be attractive for the management of COVID-19, but clinical trials must be performed in order to validate this observation. © 2021, Indian Virological Society.
引用
收藏
页码:757 / 765
页数:8
相关论文
共 50 条
  • [41] Missense mutations in SARS-CoV2 genomes from Indian patients
    Hassan, Sk. Sarif
    Choudhury, Pabitra Pal
    Roy, Bidyut
    Jana, Siddhartha Sankar
    GENOMICS, 2020, 112 (06) : 4622 - 4627
  • [42] Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms
    Golnaz Taheri
    Mahnaz Habibi
    Scientific Reports, 13
  • [43] Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms
    Taheri, Golnaz
    Habibi, Mahnaz
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [44] SARS-CoV2 Endotheliopathy: Insights from Single Cell RNAseq
    Khatun, Mst Shamima
    Qin, Xuebin
    Pociask, Derek A.
    Kolls, Jay K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (09) : 1178 - 1179
  • [45] SARS-CoV2 induced pulmonary embolism and complications from anticoagulation
    Turshudzhyan, Alla
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
  • [46] Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2
    Stephensen, C. B.
    Lietz, G.
    BRITISH JOURNAL OF NUTRITION, 2021, 126 (11) : 1663 - 1672
  • [47] No arguments for extra risk from ibuprofen in SARS-COV2 infection
    Moore, Nicholas
    THERAPIE, 2020, 75 (05): : 514 - 515
  • [48] Updates From the NASPGHAN/SPLIT SARS-CoV2 International Registry
    Kehar, Mohit
    Ebel, Noelle
    Ng, Vicky
    Lobritto, Steven
    Martinez, Mercedes
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 74 (02): : E43 - E44
  • [49] Can Tenofovir diphosphate be a candidate drug for Sars-Cov2? First clinical perspective
    Kutlu, Omer
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (01)
  • [50] Initiation of Antiviral Treatment in SARS-CoV2: Modeling Viral Dynamics and Drug Properties
    Rosenbloom, Daniel Scholes
    Zhao, Ping
    Sinha, Vikram
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (09): : 481 - 483